Literature DB >> 34796378

MiR-98-3p regulates ovarian granulosa cell proliferation and apoptosis in polycystic ovary syndrome by targeting YY1.

Min Hu1, Tian Gao2, Ying Du3.   

Abstract

Polycystic ovary syndrome (PCOS) is a common endocrinopathy related to female infertility. We investigated the function of the microRNA-98-3p (miR-98-3p)/Yin-Yang-1 (YY1) axis to the pathophysiological processes in PCOS mice. A mouse model of PCOS was established using dehydroepiandrosterone (DHEA). Hematoxylin and eosin (HE) staining was used to assess morphologic changes of the ovaries. Hormonal serum levels were measured by ELISA. Estrogen synthesis in OGCs was measured using chemiluminescence immunoassay. The viability, cell cycle, and apoptosis of ovarian granulosa cells (OGCs) were assessed by CCK-8, flow cytometry, and western blot. Luciferase reporter assays were conducted to examine the binding of miR-98-3p to YY1. YY1 was upregulated, while miR-98-3p was downregulated both in the ovarian tissues of PCOS mice and OGCs separated from PCOS mice and patients. YY1 Knockdown promoted OGC proliferation and inhibited apoptosis as well as increased estrogen production in OGCs. YY1 was verified to be targeted by miR-98-3p. Additionally, YY1 overexpression prevented the effects of miR-98-3p overexpression on the proliferation and apoptosis of OGCs. Importantly, miR-98-3p attenuated ovarian injury in PCOS mice. MiR-98-3p targets and downregulates YY1 expression, thereby affecting the proliferation and apoptosis of OGCs in PCOS.
© 2021. The Author(s) under exclusive licence to The Japanese Society for Clinical Molecular Morphology.

Entities:  

Keywords:  MiR-98-3p; Ovarian granulosa cells; Polycystic ovary syndrome; YY1

Mesh:

Substances:

Year:  2021        PMID: 34796378     DOI: 10.1007/s00795-021-00307-4

Source DB:  PubMed          Journal:  Med Mol Morphol        ISSN: 1860-1499            Impact factor:   2.309


  26 in total

Review 1.  Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications.

Authors:  Evanthia Diamanti-Kandarakis; Andrea Dunaif
Journal:  Endocr Rev       Date:  2012-10-12       Impact factor: 19.871

2.  Correlation of hyperandrogenism with hyperinsulinism in polycystic ovarian disease.

Authors:  G A Burghen; J R Givens; A E Kitabchi
Journal:  J Clin Endocrinol Metab       Date:  1980-01       Impact factor: 5.958

3.  The Yin Yang-1 (YY1) protein undergoes a DNA-replication-associated switch in localization from the cytoplasm to the nucleus at the onset of S phase.

Authors:  Linda Palko; Hank W Bass; Maroun J Beyrouthy; Myra M Hurt
Journal:  J Cell Sci       Date:  2004-01-26       Impact factor: 5.285

Review 4.  Polycystic ovary syndrome.

Authors:  Ricardo Azziz; Enrico Carmina; ZiJiang Chen; Andrea Dunaif; Joop S E Laven; Richard S Legro; Daria Lizneva; Barbara Natterson-Horowtiz; Helena J Teede; Bulent O Yildiz
Journal:  Nat Rev Dis Primers       Date:  2016-08-11       Impact factor: 52.329

5.  Consensus on women's health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group.

Authors:  Bart C J M Fauser; Basil C Tarlatzis; Robert W Rebar; Richard S Legro; Adam H Balen; Roger Lobo; Enrico Carmina; Jeffrey Chang; Bulent O Yildiz; Joop S E Laven; Jacky Boivin; Felice Petraglia; C N Wijeyeratne; Robert J Norman; Andrea Dunaif; Stephen Franks; Robert A Wild; Daniel Dumesic; Kurt Barnhart
Journal:  Fertil Steril       Date:  2011-12-06       Impact factor: 7.329

Review 6.  Adipocyte and steroidogenic cell cross-talk in polycystic ovary syndrome.

Authors:  Sebastião Freitas de Medeiros; Raymond Joseph Rodgers; Robert John Norman
Journal:  Hum Reprod Update       Date:  2021-06-22       Impact factor: 15.610

7.  Truncated YY1 interacts with BASP1 through a 339KLK341 motif in YY1 and suppresses vascular smooth muscle cell growth and intimal hyperplasia after vascular injury.

Authors:  Fernando S Santiago; Yue Li; Ling Zhong; Mark J Raftery; Laurence Lins; Levon M Khachigian
Journal:  Cardiovasc Res       Date:  2021-09-28       Impact factor: 10.787

8.  Diagnosis and treatment of polycystic ovary syndrome: an Endocrine Society clinical practice guideline.

Authors:  Richard S Legro; Silva A Arslanian; David A Ehrmann; Kathleen M Hoeger; M Hassan Murad; Renato Pasquali; Corrine K Welt
Journal:  J Clin Endocrinol Metab       Date:  2013-10-22       Impact factor: 5.958

9.  Dietary betaine prevents obesity through gut microbiota-drived microRNA-378a family.

Authors:  Jingjing Du; Peiwen Zhang; Jiang Luo; Linyuan Shen; Shunhua Zhang; Hao Gu; Jin He; Linghui Wang; Xue Zhao; Mailing Gan; Liu Yang; Lili Niu; Ye Zhao; Qianzi Tang; Guoqing Tang; Dongmei Jiang; Yanzhi Jiang; Mingzhou Li; Anan Jiang; Long Jin; Jideng Ma; Surong Shuai; Lin Bai; Jinyong Wang; Bo Zeng; Xuewei Li; Li Zhu
Journal:  Gut Microbes       Date:  2021 Jan-Dec

Review 10.  Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome.

Authors:  Helena J Teede; Marie L Misso; Michael F Costello; Anuja Dokras; Joop Laven; Lisa Moran; Terhi Piltonen; Robert J Norman
Journal:  Fertil Steril       Date:  2018-07-19       Impact factor: 7.329

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.